Tango Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
TRV GP IV, LLC | 02/13/2025 | 16.86 M | $52.09 M | 0.00% | 15.54% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 10.74 M | $33.17 M | 100.00% | 9.89% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 10.63 M | $32.85 M | -20.25% | 9.80% |
02/14/2025 | 10.38 M | $32.08 M | 100.00% | 9.57% | |
NEXTECH INVEST LTD. | 02/14/2025 | 5.53 M | $17.10 M | 0.00% | 5.10% |
GILEAD SCIENCES, INC. | 02/13/2025 | 4.85 M | $15.00 M | 100.00% | 4.47% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.38 M | $13.53 M | 0.39% | 4.04% |
FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.00 M | $12.36 M | 100.00% | 3.69% |
VANGUARD GROUP INC | 02/11/2025 | 3.99 M | $12.31 M | 9.32% | 3.67% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 3.35 M | $10.34 M | -33.40% | 3.08% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 3.28 M | $10.13 M | 22.03% | 3.02% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.80 M | $8.67 M | 100.00% | 2.58% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 2.71 M | $8.38 M | 0.00% | 2.50% |
SIREN, L.L.C. | 02/14/2025 | 2.60 M | $8.05 M | 0.00% | 2.40% |
BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 1.73 M | $5.35 M | 100.00% | 1.60% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.39 M | $4.29 M | 1.33% | 1.28% |
CASDIN CAPITAL, LLC | 02/14/2025 | 1.19 M | $3.67 M | 0.00% | 1.10% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 708,385 | $2.19 M | 0.00% | 0.65% |
BESSEMER GROUP INC | 02/13/2025 | 708,384 | $2.19 M | 0.00% | 0.65% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 662,776 | $2.05 M | 83.75% | 0.61% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 655,158 | $2.03 M | 100.00% | 0.60% |
SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 630,000 | $1.95 M | 0.00% | 0.58% |
ORBIMED ADVISORS LLC | 02/14/2025 | 550,000 | $1.70 M | 100.00% | 0.51% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 513,429 | $1.59 M | 5.38% | 0.47% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 495,106 | $1.53 M | 100.00% | 0.46% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 486,888 | $1.50 M | -10.42% | 0.45% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 474,955 | $1.47 M | -20.72% | 0.44% |
UBS GROUP AG | 02/14/2025 | 414,473 | $1.28 M | -5.98% | 0.38% |
WOODLINE PARTNERS LP | 02/14/2025 | 394,397 | $1.22 M | 100.00% | 0.36% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 347,271 | $1.07 M | 100.00% | 0.32% |
WALLEYE CAPITAL LLC | 02/13/2025 | 287,052 | $886,991 | 101.33% | 0.26% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 249,646 | $771,406 | 100.00% | 0.23% |
CONGRESS ASSET MANAGEMENT CO /MA | 01/30/2025 | 227,989 | $704,486 | 9.05% | 0.21% |
TRV GP VI, LLC | 02/13/2025 | 194,174 | $599,998 | 100.00% | 0.18% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 192,259 | $594,080 | -6.13% | 0.18% |
ALGERT GLOBAL LLC | 02/14/2025 | 162,300 | $502,000 | 100.00% | 0.15% |
FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 154,947 | $478,786 | 0.00% | 0.14% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 138,247 | $427,183 | -3.46% | 0.13% |
FRANKLIN RESOURCES INC | 02/12/2025 | 126,553 | $391,049 | 670.40% | 0.12% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 121,993 | $377,000 | 100.00% | 0.11% |
D. E. SHAW & CO., INC. | 02/14/2025 | 114,827 | $354,815 | 100.00% | 0.11% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 110,448 | $341,284 | 12.37% | 0.10% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 103,020 | $318,331 | -7.80% | 0.09% |
PDT PARTNERS, LLC | 02/14/2025 | 102,807 | $317,674 | 100.00% | 0.09% |
BARCLAYS PLC | 02/13/2025 | 99,774 | $307,000 | -20.99% | 0.09% |
JANE STREET GROUP, LLC | 02/14/2025 | 95,229 | $294,258 | 87.59% | 0.09% |
SWISS NATIONAL BANK | 02/10/2025 | 94,900 | $293,241 | 13.11% | 0.09% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 86,445 | $267,000 | 90.95% | 0.08% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 81,045 | $250,429 | 153.11% | 0.07% |
XTX TOPCO LTD | 02/13/2025 | 77,937 | $240,825 | 76.36% | 0.07% |
Tango Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 157 institutional investors and hedge funds held shares of Tango Therapeutics, Inc.. The most heavily invested institutionals were:
TRV GP IV, LLC: 16.86 M
TCG Crossover Management, LLC: 10.74 M
EcoR1 Capital, LLC: 10.63 M
Nextech Invest Ltd.: 5.53 M
GILEAD SCIENCES, INC.: 4.85 M
BlackRock Funding, Inc. /DE: 4.38 M
98.10% of Tango Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 107.80 M shares in the last 24 months. This purchase volume represents approximately $328.80 M in transactions.